CETUXIMAB COMBINED WITH INFUSIONAL 5-FLUOROURACIL/FOLINIC ACID AND OXALIPLATIN IN METASTATIC COLORECTAL CANCER: POOLED ANALYSIS OF COIN AND OPUS STUDY DATA by Taieb, J, Maughan, T, Bokemeyer, C, Van Cutsem, E, Brodowicz, T, Folprecht, G, Esser, R, Schlichting, M, Tabernero, J

Applications of Nanopore sequencing in precision cancer medicine by Dyshlovoy, SA, Paigin, S, Afflerbach, A, Lobermeyer, A, Werner, S, Schüller, U, Bokemeyer, C, Schuh, AH, Bergmann, L, von Amsberg, G, Joosse, SA

Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: pooled analysis of 2879 patients from AGIT... by Salem, M, Yin, J, Weinberg, B, Renfro, L, Pederson, L, Maughan, T, Adams, R, Van Cutsem, E, Falcone, A, Tebbutt, N, Seymour, M, Díaz-Rubio, E, Aranda, E, Bokemeyer, C, Heinemann, V, Wasan, H, De Gramont, A, Grothey, A, Shi, Q, Sargent, D, Marshall, J

NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer. by Gnjatic, S, Cao, Y, Reichelt, U, Yekebas, E, Nölker, C, Marx, A, Erbersdobler, A, Nishikawa, H, Hildebrandt, Y, Bartels, K, Horn, C, Stahl, T, Gout, I, Filonenko, V, Ling, K, Cerundolo, V, Luetkens, T, Ritter, G, Friedrichs, K, Leuwer, R, Hegewisch-Becker, S, Izbicki, JR, Bokemeyer, C, Old, L, Atanackovic, D

Personalizing survival predictions in advanced colorectal cancer: The ARCAD nomogram project by Sjoquist, KM, Renfro, LA, Simes, RJ, Tebbutt, NC, Clarke, S, Seymour, MT, Adams, R, Maughan, TS, Saltz, L, Goldberg, RM, Schmoll, H-J, Van Cutsem, E, Douillard, J-Y, Hoff, PM, Hecht, JR, Tournigand, C, Punt, CJA, Koopman, M, Hurwitz, H, Heinemann, V, Falcone, A, Porschen, R, Fuchs, C, Diaz-Rubio, E, Aranda, E, Bokemeyer, C, Souglakos, I, Kabbinavar, FF, Chibaudel, B, Meyers, JP, Sargent, DJ, De Gramont, A, Zalcberg, JR